Search Within

Howard Scher

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (127)
  2. Meeting Abstract (70)
  3. Research Letter (2)
Groups
  1. Department of Medicine (199)
  2. Epidemiology and Biostatistics (199)
  3. Genitourinary Oncology Service (199)
  4. Solid Tumor Oncology Division (199)
  5. Biostatistics Service (158)
  6. GSK Faculty (107)

More Groups

People
  1. Glenn Heller (88)
  2. Michael Morris (65)
  3. Nikolaus Schultz (42)
  4. Daniel Danila (39)
  5. David Solit (37)
  6. Steven Larson (37)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (62)
  2. Clinical Cancer Research (23)
  3. Cancer Research (13)
  4. Urology (7)
  5. European Urology (6)
  6. Journal of Nuclear Medicine (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (65)
  2. American Association for Cancer Research (43)
  3. Elsevier Science, Inc. (19)
  4. Nature Publishing Group (14)
  5. Elsevier Inc. (7)
  6. Society of Nuclear Medicine (6)

More Publishers

Results (199)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical states in prostate cancer: Toward a dynamic model of disease progression
    Journal Article

    Scher, H. I.; Heller, G.
    Urology (2000)

    Fulltext@MSK | Save
  • Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models
    Journal Article

    Agus, D. B.; Scher, H. I.; Higgins, B.; Fox, W. D.; Heller, G.; Fazzari, M.; Cordon-Cardo, C.; Golde, D. W.
    Cancer Research (1999)

    Fulltext@MSK | Save
  • A new parameter for measuring metastatic bone involvement by prostate cancer: The Bone Scan Index
    Journal Article

    Imbriaco, M.; Larson, S. M.; Yeung, H. W.; Mawlawi, O. R.; Erdi, Y.; Venkatraman, E. S.; Scher, H. I.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • Effect of patient education on data quality: Implications for assessing hereditary cancer risk in prostate cancer patients
    Meeting Abstract

    Brener, D.; Altwerger, J.; Capasso, M.; Satagopan, J.; Schluger, A.; Schulz, C.; Thayer, J.; Scher, H.; Fair, W.; Offit, K.
    American Journal of Human Genetics (1997)

    Fulltext@MSK | Save
  • Cigarette smoking and chromosome 9 alterations in bladder cancer
    Journal Article

    Zhang, Z. F.; Shu, X. M.; Cordon-Cardo, C.; Orlow, I.; Lu, M. L.; Millon, T. V.; Cao, P. Q.; Connolly-Jenks, C.; Dalbagni, G.; Lianes, P.; more...
    Cancer Epidemiology Biomarkers and Prevention (1997)

    Fulltext@MSK | Save
  • Chromosome 16q harbors two putative tumor suppressor genes in prostate cancer
    Meeting Abstract

    Osman, I.; Scher, H.; Orlow, I.; Lacombe, L.; Zhang, Z. F.; Cordon-Cardo, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Cigarette smoking and chromosome 9 alterations in bladder cancer
    Meeting Abstract

    Zhang, Z. F.; Shu, X. M.; Cordon-Cardo, C.; Orlow, I.; Lianes, P.; Lacombe, L.; Cao, P.; Sarkis, A.; Dalbagni, G.; Reuter, V.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatc cancer: A trial with 10-ethyl-deaza-aminopterin
    Journal Article

    Schultz, P. K.; Kelly, W. K.; Begg, C.; Liebertz, C.; Cohen, L.; Scher, H. I.
    Urology (1994)

    Fulltext@MSK | Save
  • Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer
    Journal Article

    Seidman, A. D.; Scher, H. I.; Gabrilove, J. L.; Bajorin, D. F.; Motzer, R. J.; O'Dell, M.; Curley, T.; Dershaw, D. D.; Quinlivan, S.; Tao, Y.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save